臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51786073 線上人數 : 997 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"liu y n"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 6-15 / 128 (共13頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-06-27T06:59:56Z	IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer	Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; CHONG-JEN YU; Shih J.-Y.
臺大學術典藏	2022-06-27T06:59:44Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	Lin Y.-T.; Tsai T.-H.; Wu S.-G.; Liu Y.-N.; CHONG-JEN YU; Shih J.-Y.
臺大學術典藏	2022-06-27T06:59:43Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2022-03-04T05:33:27Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:31Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-14T07:10:40Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-01-08T04:31:30Z	Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma	Gow C.-H.; MIN-SHU HSIEH; Liu Y.-N.; Lee Y.-H.; Shih J.-Y.
臺大學術典藏	2021-11-03T02:33:00Z	Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma	Gow C.-H.; Hsieh M.-S.; Liu Y.-N.; Lee Y.-H.; JIN-YUAN SHIH
臺大學術典藏	2021-09-15T01:20:52Z	IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer	Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU; Chang Y.-L.; Yu C.-J.; Shih J.-Y.
臺大學術典藏	2021-09-15T01:20:50Z	MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process	Wang H.-Y.; Liu Y.-N.; Wu S.-G.; CHIA-LANG HSU; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; Shih J.-Y.

顯示項目 6-15 / 128 (共13頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目